Showing results (241-250 of 415) with videos related to

Sort By:
Pageof 42
Radiology|January 21, 2011
Classification of Alzheimer disease, mild cognitive impairment, and normal cognitive status with large-scale network analysis based on resting-state functional MR imagingGang Chen, B Douglas Ward, Chunming Xie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2013
T cell Ig and mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatasesKiera L Clayton, Matthew S Haaland, Matthew B Douglas-Vail, et al.
Blood|March 31, 2005
Internal tandem duplications of the FLT3 gene are present in leukemia stem cellsMark Levis, Kathleen M Murphy, Rosalyn Pham, et al.
Blood|January 17, 2004
Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemiaB Douglas Smith, Mark Levis, Miloslav Beran, et al.
Stem Cells Translational Medicine|March 16, 2017
Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex VivoKatherine L B Knorr, Laura E Finn, B Douglas Smith, et al.
Zookeys|May 7, 2019
World catalogue of the genus-group names in Elateridae (Insecta, Coleoptera). Part I: Agrypninae, Campyloxeninae, Hemiopinae, Lissominae, Oestodinae, Parablacinae, Physodactylinae, Pityobiinae, Subprotelaterinae, TetralobinaeRobin Kundrata, Magdalena Kubaczkova, Alexander S Prosvirov, et al.
JCO Oncology Practice|February 17, 2021
Developing Workshops to Enhance Hope Among Patients With Metastatic Breast Cancer and Oncologists: A Pilot StudyMirat Shah, Anna Ferguson, Phyllis Dvora Corn, et al.
Leukemia & Lymphoma|April 5, 2018
Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patientsTara M Robinson, Gabrielle T Prince, Chris Thoburn, et al.
Blood|November 25, 2003
Characterization of clonogenic multiple myeloma cellsWilliam Matsui, Carol Ann Huff, Qiuju Wang, et al.
Leukemia Research|November 12, 2021
A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CMLJonathan A Webster, Tara M Robinson, Amanda L Blackford, et al.
Pageof 42